Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials

By afschroeder • August 13, 2025

Sheppard JP, Lakshmanan S, Palatnic L, Dahal S, Roy SK, Bhatt DL, Budoff MJ, Nelson JR. Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials. Acta Cardiol. 2025 Aug 12:1-13. doi: 10.1080/00015385.2025.2538404. Epub ahead of print. PMID: 40795199.

Tags: Cardiology/Epi, coronary artery disease, coronary imaging, docosahexaenoic acid, Eicosapentaenoic acid, Harbor UCLA, meta-analysis, Omega-3 fatty acids, Publications

High agreement of coronary artery calcification scores between full-dose (6.5 mSv) and reduced-dose (1.5 mSv) chest computed tomography: A retrospective analysis of COPDGene

Moore JM, Pratte KA, Ferguson C, Casaburi R, Iskander B, Abbasi A, Alapati P, Chilukuri S, Narashim A, Budoff MJ, Rossiter HB. High agreement of[...]

Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) maintains muscle progenitor identity by stabilizing the Ppp1r1b-lncRNA-PRC2 complex

Kang X, Zhao Y, Nelson SF, Pyle A, Lusis AJ, Touma M. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) maintains muscle progenitor identity by stabilizing the Ppp1r1b-lncRNA-PRC2[...]

Outcomes of Early Sodium-Glucose Cotransporter 2 Inhibitor Use in Takotsubo Syndrome: Insights from a Multicenter Real-World Cohort Study

Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early[...]